BeyondSpring Inc. (NASDAQ: BYSI)
$1.6800
+0.0300 ( +0.30% ) 7.2K
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.